Effect of liraglutide 3.0 mg on eating behavior in patients with obesity
Introduction. One of the objectives of weight loss in obesity is to prevent metabolic disorders associated with it. An important component in the maintenance of the achieved results is a change of eating behavior.Goal: to study the effect of liraglutide 3.0 mg on the dynamics of metabolic parameters and eating behavior in patients with obesity. Materials and methods. The study enrolled 42 obese patients in whom anthropometric parameters, metabolic parameters, and eating behavior were assessed with Dutch Eating Behavior Questionnaire (DEBQ). Patients were divided into 2 groups, one of which rec... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Reihe/Periodikum: | Медицинский совет, Vol 0, Iss 7, Pp 156-164 (2021) |
Verlag/Hrsg.: |
Remedium Group LLC
|
Schlagwörter: | glucagon-like peptide-1 agonist / weight loss / leptin / dutch questionnaire / lifestyle modification / Medicine / R |
Sprache: | Russian |
Permalink: | https://search.fid-benelux.de/Record/base-27409561 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.21518/2079-701X-2021-7-156-164 |